ATE53576T1 - Substituierte 2-oxindole-1-carboxamide als zwischenprodukte. - Google Patents

Substituierte 2-oxindole-1-carboxamide als zwischenprodukte.

Info

Publication number
ATE53576T1
ATE53576T1 AT87200969T AT87200969T ATE53576T1 AT E53576 T1 ATE53576 T1 AT E53576T1 AT 87200969 T AT87200969 T AT 87200969T AT 87200969 T AT87200969 T AT 87200969T AT E53576 T1 ATE53576 T1 AT E53576T1
Authority
AT
Austria
Prior art keywords
oxindols
carboxamides
substituted
carbons
intermediate products
Prior art date
Application number
AT87200969T
Other languages
English (en)
Inventor
Bernard Kadin Saul
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE53576T1 publication Critical patent/ATE53576T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87200969T 1984-05-04 1985-04-30 Substituierte 2-oxindole-1-carboxamide als zwischenprodukte. ATE53576T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04
US06/714,012 US4569942A (en) 1984-05-04 1985-03-22 N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Publications (1)

Publication Number Publication Date
ATE53576T1 true ATE53576T1 (de) 1990-06-15

Family

ID=27085497

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85303044T ATE44380T1 (de) 1984-05-04 1985-04-30 N,3-disubstituierte 2-oxindol-1-carboxamide als analgetische und antiinflammatorische mittel.
AT87200969T ATE53576T1 (de) 1984-05-04 1985-04-30 Substituierte 2-oxindole-1-carboxamide als zwischenprodukte.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT85303044T ATE44380T1 (de) 1984-05-04 1985-04-30 N,3-disubstituierte 2-oxindol-1-carboxamide als analgetische und antiinflammatorische mittel.

Country Status (11)

Country Link
US (1) US4569942A (de)
EP (2) EP0244918B1 (de)
AT (2) ATE44380T1 (de)
AU (1) AU554290B2 (de)
CA (1) CA1255658A (de)
DE (2) DE3578173D1 (de)
DK (1) DK162644C (de)
GR (1) GR851061B (de)
IL (1) IL75077A (de)
NZ (1) NZ211938A (de)
PH (1) PH22981A (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582890D1 (de) * 1984-02-07 1991-06-20 Pfizer 2-oxindolzwischenprodukte.
US4730004A (en) * 1986-01-22 1988-03-08 Pfizer Inc. Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides
US4791131A (en) * 1985-07-09 1988-12-13 Pfizer Inc. Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides
US4678802A (en) * 1985-07-09 1987-07-07 Pfizer Inc. 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents
US5081131A (en) * 1986-01-13 1992-01-14 American Cyanamid Company Omega-((hetero)alkyl)benz(cd)-indol-2-amines
DK288287A (da) * 1986-06-09 1987-12-10 Pfizer Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
EP0419561A1 (de) * 1988-06-14 1991-04-03 Schering Corporation Heterobicyclische verbindungen mit antientzündungsaktivität
US5182289A (en) * 1988-06-14 1993-01-26 Schering Corporation Heterobicyclic compounds having antiinflammatory activity
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US4952703A (en) * 1989-05-25 1990-08-28 Pfizer Inc. Intermediates for making 2-oxindole-1-carboxamides
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5179119A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
WO1991009598A1 (en) * 1990-01-05 1991-07-11 Pfizer Inc. Azaoxindole derivatives
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
DK0683777T3 (da) * 1993-02-09 1997-04-28 Pfizer Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler
BR9404929A (pt) * 1993-04-09 1999-07-27 Sony Corp Processo e aparelho para codificação de imagens e suporte de gravação de imagens
US5359068A (en) * 1993-06-28 1994-10-25 Pfizer Inc. Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
US6469181B1 (en) 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
US7186745B2 (en) 2001-03-06 2007-03-06 Astrazeneca Ab Indolone derivatives having vascular damaging activity
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2002349675A1 (en) * 2001-12-05 2003-06-17 Shionogi And Co., Ltd. Derivative having hiv integrase inhibitory activity
JP2005535576A (ja) * 2002-04-22 2005-11-24 ファイザー・プロダクツ・インク シクロオキシゲナーゼ−2の選択的阻害薬としてのインドール−2−オン類
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
AR056317A1 (es) * 2005-04-20 2007-10-03 Xenon Pharmaceuticals Inc Compuestos de oxindol y composicion farmaceutica
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
JP5460324B2 (ja) 2006-10-12 2014-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド 治療剤としてのスピロ−オキシインドール化合物の使用
DK2350090T3 (en) 2008-10-17 2015-09-07 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
EP2350091B1 (de) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindol verbindungen und ihre verwendung als therapeutische wirkstoffe
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
WO2011047174A1 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
US9504671B2 (en) 2010-02-26 2016-11-29 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
WO2016179157A1 (en) 2015-05-05 2016-11-10 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
BR112022008061A2 (pt) * 2019-11-01 2022-07-12 Fmc Corp Processo eficaz para síntese de 2-amino-5-cloro-n,3-dimetilbenzamida

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (de) * 1963-06-06
GB1089071A (en) * 1964-02-28 1967-11-01 Merck & Co Inc Indole derivatives
US3462450A (en) * 1966-06-29 1969-08-19 Merck & Co Inc Chemical compounds
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
US3631177A (en) * 1967-04-18 1971-12-28 Smith Kline French Lab 3-phenacyl-2-oxoindolines
US3519592A (en) * 1967-04-18 1970-07-07 Smithkline Corp Indole compounds
BE714717A (de) * 1967-05-12 1968-09-30
FR7337M (de) * 1968-01-11 1969-10-13
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4012394A (en) * 1973-02-16 1977-03-15 Labaz Indole derivatives
US3975531A (en) * 1973-10-02 1976-08-17 A. H. Robins Company, Incorporated 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof
US4221716A (en) * 1979-02-16 1980-09-09 A. H. Robins Company, Inc. Intermediate and process for the preparation of 7-acylindolin-2-ones

Also Published As

Publication number Publication date
AU4193885A (en) 1985-11-07
EP0244918A2 (de) 1987-11-11
EP0244918B1 (de) 1990-06-13
DE3578173D1 (de) 1990-07-19
EP0244918A3 (en) 1989-02-22
DK162644B (da) 1991-11-25
IL75077A0 (en) 1985-09-29
EP0164860B1 (de) 1989-07-05
DK197685D0 (da) 1985-05-02
IL75077A (en) 1988-03-31
US4569942A (en) 1986-02-11
GR851061B (de) 1985-11-25
DE3571320D1 (en) 1989-08-10
ATE44380T1 (de) 1989-07-15
NZ211938A (en) 1988-08-30
PH22981A (en) 1989-02-24
DK197685A (da) 1985-11-05
EP0164860A1 (de) 1985-12-18
AU554290B2 (en) 1986-08-14
DK162644C (da) 1992-04-13
CA1255658A (en) 1989-06-13

Similar Documents

Publication Publication Date Title
ATE53576T1 (de) Substituierte 2-oxindole-1-carboxamide als zwischenprodukte.
DE3782883D1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
DE3777735D1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
IE791099L (en) Histamine h2 antagonists
ES8800168A1 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
GR3003776T3 (de)
ATE44381T1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung.
DE3582890D1 (de) 2-oxindolzwischenprodukte.
ATE33648T1 (de) 1-(4-(benzothia- oder -oxazol-2-ylthio- oder -2- yloxy) phenyl>-1,3,5-triazin-2,4,6(1h,3h,5h)trione, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3584652D1 (de) 2,2,6,6-tetramethyl-4-piperidinyl-derivate und ihre verwendung als lichtstabilisatoren.
EP0190712A3 (en) Pyrrole-3-carboxylate cardiotonic agents
ES8506290A1 (es) Procedimiento para la obtencion de derivados de acido barbiturico
DE69305587D1 (de) 2-substituierte Pyrimidine und ihre Verwendung als Herbizide
ATE141918T1 (de) Isoquinolinderivate
ES2061406A1 (es) Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
ZA868557B (en) Heterocyclic compounds
DE3775905D1 (de) Purin-histamin-h1-antagonisten, ihre herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time